多原发癌中非小细胞肺癌27例的治疗探讨

The Report of 27 Cases of Non-small Cell Lung Cancer in Multiple Primary Cancer

  • 摘要: 目的:探讨多原发癌中的肺癌的诊断,治疗及预后。方法:2000年1月至2004年12月,共收治肺癌患者754例。对其临床资料进行了回顾性的分析。根据Warran和Gates提出的多原发癌的诊断标准,筛选出了27例多原发癌中的非小细胞肺癌(NSCLC),并对其诊断、治疗及予后进行了总结。结果:27例患者中同时性者4例,异时性者23例。本组27例总的手术切除率为77.8%(21/27),根治术为59.0%(16/27),根治性术者1年生存率为80.0%,3年生存率为46.7%;姑息术者1年生存率为33.0%,3年生存率为11.0%。结论:有恶性肿瘤手术史者,特别是无瘤生存期超过两年者,当肺内出现孤立结节,或者无肿瘤病史者肺内不同肺叶,同时或异时出现孤立结节,纵隔及全身无转移癌者,要考虑到多原发癌中的肺癌的可能,应与肺转移癌鉴别,一旦确诊为原发肺癌,争取行根治术,以获取较好预后。

     

    Abstract: Objective: To investigate the diagnosis, treatment and prognosis of lung cancer in Multiple Primary Carcinoma (MPC). Methods: Among the 754 cases with lung cancer admitted from January 2000 to December 2004, 27 non-small cell lung cancer (NSCLC) patients with MPC were selected based on the Warran and Gates MPC diagnosis criteria. Diagnosis, treatment and prognosis of the patients were summarized. Results: In the 27 patients, 4 suffered synchronous and 23 suffered metachronous symptoms. The surgical resection rate was 77.85% (21/27) and the radical correction rate was 59% (16/27). The 1-year and 3-year survival rates after radical resection were 80% and 46.7%, respectively, compared to 33% and 11% after palliative resection. Conclusions: MPC should be suspected in patients with a past history of malignant cancer. MPC should especially be considered in those with a tumor-free survival time of more than 2 years or in patients who have synchronous or metachronous solitary nodules in different lung lobes, without a history of carcinoma or mediastinal or systemic metastasis. MPC must be differentiated from lung metastasis. Whenever primary lung cancer is diagnosed, radical resection should be the first course of treatment to realize the best prognosis.

     

/

返回文章
返回